Thoroughness of mediastinal staging in stage IIIA non-small cell lung cancer

Keyphrases

• Non-small Cell Lung Cancer (NSCLC) 100%
• Mediastinal Staging 100%
• Positron Emission Tomography 75%
• Confidence Interval 50%
• Patient Characteristics 50%
• Odds Ratio 25%
• Non-associated 25%
• Adjusted Odds Ratio 25%
• Pathologic 25%
• Young Age 25%
• Older Patients 25%
• Medicare Claims 25%
• Histologic 25%
• Lymph Node 25%
• Cancer Treatment 25%
• Surveillance Epidemiology 25%
• Patient-specific Therapy 25%
• Multivariable Logistic Regression 25%
• Marital Status 25%
• Medicare Beneficiaries 25%
• Practice Patterns 25%
• Underutilization 25%
• Non-small Cell Lung Cancer Patients 25%
• Cancer-specific 25%
• Curative Intent 25%
• Medicare Database 25%
• Invasive Mediastinal Staging 25%

Medicine and Dentistry

• Non Small Cell Lung Cancer 100%
• Positron Emission Tomography 60%
• Medicare 60%
• Odds Ratio 40%
• Cancer Therapy 20%
• Malignant Neoplasm 20%
• Clinical Stage 20%
• Lymph Node 20%
• Logistic Regression Analysis 20%
• Surveillance, Epidemiology, and End Results 20%
• Patient Characteristics 20%
• Marital Status 20%

Nursing and Health Professions

• Non Small Cell Lung Cancer 100%
• Positron Emission Tomography 60%
• Medicare 60%
• Odds Ratio 40%
• Confidence Interval 40%
• Practice Guideline 40%
• Logistic Regression Analysis 20%
• Malignant Neoplasm 20%
• Cancer Therapy 20%
• Marital Status 20%